MustGrow to shut Canadian unit, shift focus to U.S. biofertility market

MustGrow Biologics, a Canadian company specializing in biofertility solutions, has announced its decision to shut down its Canadian distribution subsidiary, NexusBioAg, on April 15. This move comes as the company shifts its focus from a lower-margin resale business to expanding its operations in the U.S. biofertility market. NexusBioAg, which distributed third-party agricultural inputs to Canadian farmers, operated in a highly competitive market segment with limited profit margins. The remaining inventory will be sold through existing channels in the coming months.

The decision to close NexusBioAg follows a significant supply shortfall that has occurred as demand for MustGrow's flagship product, TerraSante, has outpaced production. TerraSante, a mustard-derived organic biofertility product, has gained traction among large U.S. growers, with the demand-supply imbalance persisting into the current year. To address this issue, MustGrow has raised $2 million in equity financing in January and secured an additional $2 million credit facility from the Canadian Imperial Bank of Commerce, backed by Export Development Canada. This financial support is intended to bolster inventory build-up and support the company's expansion plans.

MustGrow's strategy relies on third-party manufacturers, enabling the company to scale up production of TerraSante without the need for significant investments in its own facilities. This approach allows for flexibility and rapid scaling to meet growing demand. TerraSante is currently registered for sale in several U.S. states, including California and Florida, and holds certifications under the Organic Materials Review Institute (OMRI) and California's Organic Input Material program. Early data from MustGrow suggests that the product can support improved soil conditions and crop performance, making it an attractive option for organic farmers.

In addition to its U.S. focus, MustGrow is also evaluating potential partnership opportunities to expand TerraSante into international markets. The company has previously collaborated with Bayer AG, a global leader in agriculture and chemical industries, which could serve as a foundation for future international expansion. By pivoting its strategy and redirecting resources toward the U.S. market and international opportunities, MustGrow aims to capitalize on the growing demand for sustainable and effective biofertility solutions in agriculture.

The shutdown of NexusBioAg marks a strategic shift for MustGrow, reflecting the company's commitment to prioritizing high-growth opportunities in the biofertility sector. With a strong focus on expanding its U.S. presence and exploring international markets, MustGrow is well-positioned to leverage its innovative product and strategic partnerships to achieve significant growth in the coming years. The company's decision to invest in TerraSante production and distribution aligns with the global trend toward sustainable agriculture and organic farming practices, positioning MustGrow as a key player in the evolving agricultural landscape.